- Home
- RLGT vs NMRA Comparison
RLGT vs NMRA Comparison
Compare RLGT & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLGT
- NMRA
- Stock Information
- Founded
- RLGT 2001
- NMRA 2019
- Country
- RLGT United States
- NMRA United States
- Employees
- RLGT N/A
- NMRA N/A
- Industry
- RLGT Oil Refining/Marketing
- NMRA
- Sector
- RLGT Consumer Discretionary
- NMRA
- Exchange
- RLGT Nasdaq
- NMRA Nasdaq
- Market Cap
- RLGT 282.9M
- NMRA 268.5M
- IPO Year
- RLGT N/A
- NMRA 2023
- Fundamental
- Price
- RLGT $6.03
- NMRA $1.85
- Analyst Decision
- RLGT Strong Buy
- NMRA Hold
- Analyst Count
- RLGT 1
- NMRA 8
- Target Price
- RLGT $8.00
- NMRA $5.83
- AVG Volume (30 Days)
- RLGT 333.9K
- NMRA 489.7K
- Earning Date
- RLGT 11-11-2025
- NMRA 11-11-2025
- Dividend Yield
- RLGT N/A
- NMRA N/A
- EPS Growth
- RLGT 118.75
- NMRA N/A
- EPS
- RLGT 0.35
- NMRA N/A
- Revenue
- RLGT $902,696,000.00
- NMRA N/A
- Revenue This Year
- RLGT $7.61
- NMRA N/A
- Revenue Next Year
- RLGT N/A
- NMRA N/A
- P/E Ratio
- RLGT $17.15
- NMRA N/A
- Revenue Growth
- RLGT 12.49
- NMRA N/A
- 52 Week Low
- RLGT $5.44
- NMRA $0.61
- 52 Week High
- RLGT $7.94
- NMRA $17.19
- Technical
- Relative Strength Index (RSI)
- RLGT 46.75
- NMRA 57.48
- Support Level
- RLGT $5.82
- NMRA $1.70
- Resistance Level
- RLGT $6.11
- NMRA $1.93
- Average True Range (ATR)
- RLGT 0.15
- NMRA 0.13
- MACD
- RLGT -0.01
- NMRA 0.01
- Stochastic Oscillator
- RLGT 54.44
- NMRA 81.13
About RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.